Tag: ddPCR

All

Bridge Capture Matches ddPCR in Colorectal Cancer Pilot

Genomill's Bridge Capture technology achieved gold-standard sensitivity in detecting mutations in metastatic colorectal cancer patients.

Bio-Rad Expands ddPCR Offering Through Strategic Acquisition and Platform Rollout
Mimix Reference Standards for Monitoring Oncology Diagnostic Testing Workflows Introduced
ctMoniTR Project Gets new Research Findings from Biodesix and Bio-Rad
Datar Cancer Genetics Unveils Advanced Blood Test for MRD
Bio-Rad Launches New ddPCR Kits for AAV Serotypes 2 and 8
Bio-Rad Launches ddPCR Empty-Full Capsid Kit for AAV Vector Characterization
Bio-Rad and Oncocyte Partner on Transplant Monitoring with Droplet Digital PCR
Bio-Rad Announces Collaboration to Advance Personalized Monitoring of Solid Tumor Cancers
Bio-Rad Launches Test Kits for Replication Competent Viruses

All

Bio-Rad Launches SARS-CoV-2 S Variant Controls

Bio-Rad Laboratories has launched the SARS-CoV-2 S Gene Alpha, Beta, Gamma and Epsilon Variant Controls.

Blood Test May Predict Response in Metastatic HPV-Positive Throat Cancer
Amsbio Cell Free Nucleic Acid Extraction
The Race for an Ultrasensitive Coronavirus Test
Testing for SARS-CoV-2 in Wastewater
Breakthrough Blood Test Developed for Brain Tumors
Biodesix Begins Coronavirus Covid-19 Testing

All

MSU Researchers Adapt Coronavirus Test without Scarce Resources

Researchers used different reagents than those that are in short supply, and they were able to produce results in about a day using the ddPCR from Bio-Rad.

Biodesix, Streck Form Partnership on In Vitro Diagnostics
BCR-ABL %IS Kit Monitors CML Treatment Response
Microsatellite Instability Assay
Creating More Accurate Measurements of NSCLC Treatment Response
Predicting the Effectiveness of Anti-PD-L1 Therapy
New Data Show Biodesix Blood Test Reliably Detects Additional Mutations in Patients with NSCLC

Tag: ddPCR

All

Bridge Capture Matches ddPCR in Colorectal Cancer Pilot

Bio-Rad Expands ddPCR Offering Through Strategic Acquisition and Platform Rollout

Mimix Reference Standards for Monitoring Oncology Diagnostic Testing Workflows Introduced

ctMoniTR Project Gets new Research Findings from Biodesix and Bio-Rad

Datar Cancer Genetics Unveils Advanced Blood Test for MRD

Bio-Rad Launches New ddPCR Kits for AAV Serotypes 2 and 8

Bio-Rad Launches ddPCR Empty-Full Capsid Kit for AAV Vector Characterization

Bio-Rad and Oncocyte Partner on Transplant Monitoring with Droplet Digital PCR

Bio-Rad Announces Collaboration to Advance Personalized Monitoring of Solid Tumor Cancers

Bio-Rad Launches Test Kits for Replication Competent Viruses

All

Bio-Rad Launches SARS-CoV-2 S Variant Controls

Blood Test May Predict Response in Metastatic HPV-Positive Throat Cancer

Amsbio Cell Free Nucleic Acid Extraction

The Race for an Ultrasensitive Coronavirus Test

Testing for SARS-CoV-2 in Wastewater

Breakthrough Blood Test Developed for Brain Tumors

Biodesix Begins Coronavirus Covid-19 Testing

All

MSU Researchers Adapt Coronavirus Test without Scarce Resources

Biodesix, Streck Form Partnership on In Vitro Diagnostics

BCR-ABL %IS Kit Monitors CML Treatment Response

Microsatellite Instability Assay

Creating More Accurate Measurements of NSCLC Treatment Response

Predicting the Effectiveness of Anti-PD-L1 Therapy

New Data Show Biodesix Blood Test Reliably Detects Additional Mutations in Patients with NSCLC

Sorry, No Posts Found

Clinical Lab Products

Our Parent Company

Key Resources

Helpful Links